Citation Impact
Citing Papers
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
2005 StandoutNobel
Cancer in Africa 2012
2014
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens
2008
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Characterization of human blood dendritic cell subsets
2002
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Spotlight on Spotted Mice: A Review of White Spotting Mouse Mutants and Associated Human Pigmentation Disorders
2004
Mortality in immune thrombocytopenic purpura: Report of seven cases and consideration of prognostic indicators
1994
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
1997 StandoutNature
Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)
1987
Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell Neoplasms
1999
Oncogenic kinase signalling
2001 StandoutNature
Combination Chemotherapy in Refractory Immune Thrombocytopenic Purpura
1993
PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery
1993
Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa
2001
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Activating c-kit Gene Mutations in Human Germ Cell Tumors
1999
Inhibition of Spontaneous Receptor Phosphorylation by Residues in a Putative α-Helix in the KIT Intracellular Juxtamembrane Region
1999
Preservation of Venous Valve Function after Catheter-Directed and Systemic Thrombolysis for Deep Venous Thrombosis
2004
Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis
2006
Antithrombotic Therapy for VTE Disease
2016 Standout
Iron speciation at physiological pH in media containing ascorbate and oxygen
1993
Thrombolysis for acute deep vein thrombosis
2004
The role of vena caval filters in the management of venous thromboembolism
2004
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
1988 Standout
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Venous thrombectomy for lliofemoral vein thrombosis — 10-year results of a prospective randomised study
1997
Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations
2002
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
1999
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life
2000
Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation
1990
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
Inflammatory Bowel Disease
2002 Standout
Pharmacomechanical Thrombolysis and Early Stent Placement for Iliofemoral Deep Vein Thrombosis
2004
Cell-Associated Plasminogen Activation: Regulation and Physiological Functions
1988
Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis
2006
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene
2002
Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy
2001
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours
2001
Thrombolytic Therapy: Current Status
1988
Characterization of autoantibodies against the platelet glycoprotein antigens llb/llla in childhood idiopathic thrombocytopenia purpura
1995
Hematopoietic Stem-Cell Transplantation
2006 Standout
Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: A prospective randomized clinical trial
1994
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia
1992
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism
2014
Adjunctive Percutaneous Mechanical Thrombectomy for Lower-extremity Deep Vein Thrombosis: Clinical and Economic Outcomes
2006
Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function
1998
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
2004
Iliofemoral Deep Vein Thrombosis: Conventional Therapy Versus Lysis and Percutaneous Transluminal Angioplasty and Stenting
2001
Iliofemoral Deep Venous Thrombosis: Safety and Efficacy Outcome during 5 Years of Catheter-directed Thrombolytic Therapy
1997
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Short- and long-term results after thrombolytic treatment of deep venous thrombosis
2000
The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136
1998
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Biochemical and biological aspects of the plasminogen activation system
1990
Why is Erythropoietin Made in the Kidney?
2003
Proinflammatory Cytokines Lowering Erythropoietin Production
1998
Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities
2000
Comparison of Urokinase, Alteplase, and Reteplase for Catheter-directed Thrombolysis of Deep Venous Thrombosis
2004
Anemia of Chronic Disease
2005 Standout
Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors
2003
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis
1994
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
1984
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development
2010 StandoutNobel
Human T-lymphotropic retroviruses
1985 Nature
Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis: Kinetic Stabilization of the Native State
2005
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Genome organization and transactivation of the human immunodeficiency virus type 2
1987 StandoutNatureNobel
Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosis
1999
Human Immunodeficiency Virus Type 2 Infection Associated with AIDS in West Africa
1987 StandoutNobel
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
1985
Prevention and Treatment of Postphlebitic Syndrome
2001
Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan.
2000
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
2001
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Treatment of severe autoimmune disease by stem-cell transplantation
2005 Nature
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.
1998 Standout
Thrombolysis for acute deep vein thrombosis
2016
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
2003
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies
2014
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
1986
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Course of Crohn's disease after allogeneic marrow transplantation
1998
Natural History of Venous Thromboembolism
2003
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
2005
Signal transduction via the stem cell factor receptor/c-Kit
2004
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Stem Cell Factor and Hematopoiesis
1997
Paget-Schroetter syndrome: A review and Algorithm (WASPS-IR)
2015
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
2011
Characterization of an Extremely Large, Ligand-Induced Conformational Change in Plasminogen
1990 StandoutScienceNobel
Type‐I HTLV antibody in urban and rural Ghana, West Africa
1984
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1
1996
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Growth Factors and Cancer
1991 StandoutScience
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
2014
Mast cells and mastocytosis
2008
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Tissue Plasminogen Activator (rt-PA) vs Heparin in Deep Vein Thrombosis
1990
Etoposide (VP-16–213)
1985
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors
1984
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
2001
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
1999 StandoutScience
Tumors: Wounds That Do Not Heal
1986 Standout
Arteriosclerosis in normal and von Willebrand pigs: long-term prospective study and aortic transplantation study.
1982
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis
1984
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
1999
AIDS in Africa: An Epidemiologic Paradigm
1986 Science
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
1985 Standout
Works of Peter Jacobs being referenced
Transthyretin isoleucine-122 mutation in African and American blacks
2000
Treatment of Adult Acute Lymphoblastic Leukaemia
1990
Athletes' pseudoanaemia
1991
Evaluation of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex in Early Myocardial Infarction
1987
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
2000
Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies
1991
Response in serum ferritin and haemoglobin to iron therapy in blood donors
1988
Impact of the HIV epidemic and Anti-Retroviral Treatment policy on lymphoma incidence and subtypes seen in the Western Cape of South Africa, 2002–2009: Preliminary findings of the Tygerberg Lymphoma Study Group
2011
Erythropoietic adaptations to endurance training
1992
Blunted erythropoietin response to anaemia in tuberculosis
1995
Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron‐deficient blood donors
1993
The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia
1989
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm
1996
‘Sports Anemia’ - A Real or Apparent Phenomenon in Endurance-Trained Athletes?
1992
Splenic pathology in immune thrombocytopenia.
1985
Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study.
1979
Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia.
1979
Autopsy Findings in an Elderly Man Suffering from Severe von Willebrand’s Disease
1981
Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia
2000
Intestinal iron transport: studies using a loop of gut with an artificial circulation
1966
A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial
1979
Long‐term outcome of autoimmune disease following allogeneic bone marrow transplantation
1998
Results of Treatment in Immune Thrombocytopenia
1986
Human T-Cell Leukemia Virus (HTLV-I) Antibodies in Africa
1984 Science
The secretion of plasminogen activators by human myeloid leukemic cells in vitro
1983
Iron binding proteins of iron-absorbing rat intestinal mucosa.
1983
The role of thrombolytic therapy in the management of phlegmasia caerulea dolens
1979
Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
1984
The HLA linked iron loading gene in an Afrikaner population.
1987
The effects of dexamethasone and tetradecanoyl phorbol acetate on plasminogen activator release by human acute myeloid leukemia cells
1983
Rapid remission induction in adult acute non-lymphoblastic leukaemia
1978
Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia.
1986